HC Wainwright & Co. Maintains Buy on Adicet Bio, Raises Price Target to $34

Benzinga Newsdesk www.benzinga.com Positive 64.4%

Neg 0% Neu 0% Pos 64.4%

HC Wainwright & Co. analyst Robert Burns maintains Adicet Bio (NASDAQ:ACET) with a Buy and raises the price target from $27 to $34.